Cardiol Therapeutics Inc. (CRDL)
USD 0.99
(-1.56%)
USD 0.99
(-1.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -34.77 Million CAD | 41.48% |
| 2022 | -59.39 Million CAD | 29.1% |
| 2021 | -83.78 Million CAD | -504.11% |
| 2020 | -13.86 Million CAD | -104.99% |
| 2019 | -6.76 Million CAD | 58.9% |
| 2018 | -16.46 Million CAD | -659.86% |
| 2017 | -2.16 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -23.85 Million CAD | 16.01% |
| 2024 Q1 | -28.4 Million CAD | 18.13% |
| 2023 Q4 | -34.69 Million CAD | 14.03% |
| 2023 Q2 | -44.89 Million CAD | 9.13% |
| 2023 Q1 | -49.4 Million CAD | 16.82% |
| 2023 FY | -34.69 Million CAD | 41.59% |
| 2023 Q3 | -40.35 Million CAD | 10.1% |
| 2022 Q2 | -70.35 Million CAD | 5.86% |
| 2022 Q3 | -65.44 Million CAD | 6.98% |
| 2022 FY | -59.39 Million CAD | 29.1% |
| 2022 Q1 | -74.73 Million CAD | 10.8% |
| 2022 Q4 | -59.39 Million CAD | 9.25% |
| 2021 Q1 | -17.85 Million CAD | -28.76% |
| 2021 FY | -83.78 Million CAD | -504.11% |
| 2021 Q4 | -83.78 Million CAD | -193.71% |
| 2021 Q3 | -28.52 Million CAD | 12.45% |
| 2021 Q2 | -32.58 Million CAD | -82.46% |
| 2020 Q1 | -4.31 Million CAD | 36.23% |
| 2020 FY | -13.86 Million CAD | -104.99% |
| 2020 Q4 | -13.86 Million CAD | 15.34% |
| 2020 Q3 | -16.38 Million CAD | 14.95% |
| 2020 Q2 | -19.25 Million CAD | -346.43% |
| 2019 Q3 | -9.9 Million CAD | 19.15% |
| 2019 Q2 | -12.25 Million CAD | 14.29% |
| 2019 Q1 | -14.29 Million CAD | 13.17% |
| 2019 FY | -6.76 Million CAD | 58.9% |
| 2019 Q4 | -6.76 Million CAD | 31.7% |
| 2018 Q4 | -16.46 Million CAD | -1903.18% |
| 2018 FY | -16.46 Million CAD | -659.86% |
| 2018 Q1 | 2.35 Million CAD | 208.77% |
| 2018 Q2 | -1.12 Million CAD | -147.83% |
| 2018 Q3 | 912.95 Thousand CAD | 181.01% |
| 2017 FY | -2.16 Million CAD | 0.0% |
| 2017 Q4 | -2.16 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 107.988% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | -268.762% |
| Embecta Corp. | 1.31 Billion USD | 102.65% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 108.035% |
| PainReform Ltd. | -7.95 Million USD | -337.399% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -122.412% |
| SCYNEXIS, Inc. | -19.35 Million USD | -79.707% |
| Journey Medical Corporation | -9.7 Million USD | -258.155% |
| Safety Shot Inc | -2.28 Million USD | -1422.221% |
| Alpha Teknova, Inc. | 1.97 Million USD | 1861.563% |
| Bright Green Corporation | 1.84 Million USD | 1988.081% |
| Procaps Group, S.A. | 242.93 Million USD | 114.314% |
| Alvotech | 1.06 Billion USD | 103.267% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 136.912% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 146.395% |
| Cosmos Health Inc. | 8.59 Million USD | 504.775% |
| Dynavax Technologies Corporation | 106.63 Million USD | 132.61% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 107.581% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 73.421% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -122.412% |
| Theratechnologies Inc. | 24.87 Million USD | 239.814% |
| Harrow Health, Inc. | 116.41 Million USD | 129.87% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -1279.891% |
| Biofrontera Inc. | 4.05 Million USD | 957.329% |
| DURECT Corporation | -7.65 Million USD | -354.315% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | -3.717% |
| Cronos Group Inc. | -663.32 Million USD | 94.758% |
| OptiNose, Inc. | 58.06 Million USD | 159.887% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 105.578% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | -138.631% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -570.518% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 331.621% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | -446.78% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 32641.242% |
| Radius Health, Inc. | 359.28 Million USD | 109.679% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 17732.687% |
| ProPhase Labs, Inc. | 19.23 Million USD | 280.819% |
| Phibro Animal Health Corporation | 454.84 Million USD | 107.645% |
| Procaps Group S.A. | 242.93 Million USD | 114.314% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 1045.439% |
| Viatris Inc. | 17.13 Billion USD | 100.203% |
| Rockwell Medical, Inc. | 4.45 Million USD | 880.369% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -613.005% |
| SIGA Technologies, Inc. | -148.68 Million USD | 76.612% |
| Tilray Brands, Inc. | 158.97 Million USD | 121.873% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 128.527% |
| Shineco, Inc. | 29.29 Million USD | 218.719% |
| PetIQ, Inc. | 351.93 Million USD | 109.881% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -1098.487% |
| Incannex Healthcare Limited | -5.48 Million USD | -533.97% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 119.613% |
| Alimera Sciences, Inc. | 55.3 Million USD | 162.871% |
| Silver Spike Investment Corp. | -32.61 Million USD | -6.628% |
| Assertio Holdings, Inc. | -32.52 Million USD | -6.899% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -2235.778% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -587.166% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -622.336% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -323.368% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 924.597% |
| Hempacco Co., Inc. | 13.61 Million USD | 355.41% |
| Talphera, Inc. | -5.72 Million USD | -507.818% |
| Alvotech | 1.06 Billion USD | 103.267% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 586.679% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 64.044% |
| Currenc Group, Inc. | -16.57 Million USD | -109.817% |
| Kamada Ltd. | -46.43 Million USD | 25.109% |
| Indivior PLC | -33.95 Million USD | -2.419% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 13444.864% |
| Flora Growth Corp. | -713 Thousand USD | -4777.033% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -323.368% |
| Evolus, Inc. | 63.7 Million USD | 154.582% |
| HUTCHMED (China) Limited | -197.45 Million USD | 82.39% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 107.258% |
| Akanda Corp. | 3.9 Million USD | 990.499% |